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Associations between the gut microbiome
and metabolome in early life
Quang P. Nguyen1,2, Margaret R. Karagas1,3, Juliette C. Madan1,2,3,4, Erika Dade1, Thomas J. Palys1,
Hilary G. Morrison5, Wimal W. Pathmasiri6*, Susan McRitche6, Susan J. Sumner6, H. Robert Frost2† and
Anne G. Hoen1,2,3*†

Abstract
Background: The infant intestinal microbiome plays an important role in metabolism and immune development
with impacts on lifelong health. The linkage between the taxonomic composition of the microbiome and its
metabolic phenotype is undefined and complicated by redundancies in the taxon-function relationship within
microbial communities. To inform a more mechanistic understanding of the relationship between the microbiome
and health, we performed an integrative statistical and machine learning-based analysis of microbe taxonomic
structure and metabolic function in order to characterize the taxa-function relationship in early life.
Results: Stool samples collected from infants enrolled in the New Hampshire Birth Cohort Study (NHBCS) at
approximately 6-weeks (n = 158) and 12-months (n = 282) of age were profiled using targeted and untargeted
nuclear magnetic resonance (NMR) spectroscopy as well as DNA sequencing of the V4-V5 hypervariable region
from the bacterial 16S rRNA gene. There was significant inter-omic concordance based on Procrustes analysis (6
weeks: p = 0.056; 12 months: p = 0.001), however this association was no longer significant when accounting for
phylogenetic relationships using generalized UniFrac distance metric (6 weeks: p = 0.376; 12 months: p = 0.069).
Sparse canonical correlation analysis showed significant correlation, as well as identifying sets of microbe/
metabolites driving microbiome-metabolome relatedness. Performance of machine learning models varied across
different metabolites, with support vector machines (radial basis function kernel) being the consistently top ranked
model. However, predictive R2 values demonstrated poor predictive performance across all models assessed (avg: −
5.06% -- 6 weeks; − 3.7% -- 12 months). Conversely, the Spearman correlation metric was higher (avg: 0.344–6 weeks;
0.265–12 months). This demonstrated that taxonomic relative abundance was not predictive of metabolite
concentrations.
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Conclusions: Our results suggest a degree of overall association between taxonomic profiles and metabolite
concentrations. However, lack of predictive capacity for stool metabolic signatures reflects, in part, the possible role
of functional redundancy in defining the taxa-function relationship in early life as well as the bidirectional nature of
the microbiome-metabolome association. Our results provide evidence in favor of a multi-omic approach for
microbiome studies, especially those focused on health outcomes.
Keywords: Infant gut microbiome, Stool metabolome, Prediction models, Functional redundancy, Metabolism

Background
The human gut microbiome is a complex and diverse
system of microorganisms that co-inhabit the intestinal
lumen and play a crucial role in modulating human
health and disease [1, 2]. The development of the microbiota in early life is a sensitive process akin to primary
ecological succession [3], and therefore both reliant on,
and vulnerable to, external perturbations. Studies have
linked microbiome alterations to long-term health consequences, including risk of obesity [4], type I diabetes
[5], and inflammatory bowel disease [6]. As such, there
is a need to understand how the microbiome participates
in the multifactorial pathways leading to long-term disease outcomes. One key to this open question lies in the
currently undefined relationship between the taxonomic
structure of the microbiome and its metabolic phenotype. Previous studies addressing this question have
mainly focused on DNA-based profiling of microbial
functional potential, which, due to complicated regulatory mechanisms at the cellular level beyond the genome, is not equivalent to the microbiota’s realized
functional landscape [7].
There exists a bidirectional association between the
metabolome and the microbiome in the gut [8, 9]. These
low molecular weight molecules can either be nutrients
that shape the composition of the microbiome [10] or
important byproducts of host-microbe nutrient cometabolism that help regulate host metabolic homeostasis [11–13]. For example, members of the Clostridium
clusters can produce and increase serum levels of
branched chain amino acids, which are markers for insulin resistance and diabetes [14, 15]. However, studies
suggest that the fecal metabolome specifically can be
used as a readout of gut microbe metabolic functions.
Zierer et al. [16] showed, in a large cohort of adult females (n = 786) from the TwinsUK study, that around
60% of the fecal metabolome is associated with microbial
composition, where on average, 67% of variance in the
metabolome can be explained by the microbiome.
Recent studies have integrated the metabolome in
microbiome analyses of health outcomes, most notably
Lloyd et al. [17] from the integrative Human Microbiome Project. However, these studies have mostly focused on adult populations with specific metabolic
disease etiologies such as inflammatory bowel disease.

Only a limited number of studies [18–23] have simultaneously profiled the gut microbiome and metabolome
from infant stool samples. These studies have preliminarily established that metabolomic profiles shift as taxonomic abundances change between subject case/control
status [18, 20, 21, 24]. Specifically, Ayeni et al. (n = 48)
[19] and Kisuse et al. (n = 35) [23] demonstrated that
inter-sample distances calculated using metabolite abundances are correlated with those calculated from taxonomic profiles using Mantel tests across African and
Asian cohorts. However, studies to date have either focused on preterm infants [18, 20, 21] or had small sample sizes (less than 50) [19, 22, 23]. We identified a
major gap in defining microbiome-metabolome relatedness among infants from a population-based cohort capturing both early in infancy and near the first birthday,
with regards to determining the strength of association
and to identify key contributors to the overall
concordance.
Here, we present our study investigating associations
between microbe abundances assayed with 16S rRNA
sequencing and metabolomic profiles measured with 1H
NMR spectroscopy in a cohort of infants representing a
rural general population from the New Hampshire Birth
Cohort Study (NHBCS). This is a unique epidemiological cohort with multi-omic profiling of infant stool
samples at multiple time points accompanied with rich
sociodemographic, dietary and health outcomes data
[25]. Our study utilizes predictive modeling, multivariate
correlation methods and distance-based approaches to
characterize the dynamic relationship between the gut
microbiome and the gut metabolome in early life.

Results
The overall workflow and subject selection process are
described in Fig. 1. Primary analyses were performed on
paired microbiome-metabolome data sets on samples
collected at approximately 6 weeks (N = 158 samples)
and 12 months (N = 282 samples) of age (65 subjects
have paired samples collected at both time points). In
order to take advantage of the most samples from this
study, each time point was analyzed separately with sensitivity analyses performed on sample pairs. As such, the
sample size N will thereafter represent the number of
samples found in each time point rather than the

Nguyen et al. BMC Microbiology

(2021) 21:238

Page 3 of 19

Fig. 1 Overview of the analysis. Panel A describes the subject selection workflow and panel B describes the analytic pipeline

number of unique infants. After processing and filtering,
we evaluated a final taxonomic dataset of 48 genera in 6
weeks samples and 72 genera in 12 months samples.
Metabolomic profiles were represented as 208 unique
untargeted spectral bins and a concentration-fitting
method [26] was used to acquire specific relative concentrations of 36 targeted metabolites. These metabolites
were chosen based on a literature search (Table S1) for
compounds known to be associated with commensal gut
microbes. Results presented here will primarily feature
the targeted dataset, with accompanying figures and tables for the untargeted data set in the supplemental section. Figure 1 shows the overall workflow including the
sample selection process. In summary, we performed
three analyses: First, an overall concordance analysis
using ordinations with ecological distances; second, a
parametric multivariate correlation approach with a variable selection component to quantify the overall correlation and determine important factors that contribute to
the overall microbiome-metabolite association; third, a
predictive analysis approach to see if taxonomic abundance alone can accurately predict the concentrations of
specific metabolites.
Study population

Study subject characteristics are summarized in Table 1
separately for both subjects providing samples at 6-week
of age (n = 158) and 12-months of age (n = 282). Characteristic of our population, most infants are White (97.5%
among subjects contributing a 6-week sample; 95.4%
among subjects contributing a 12-month sample), delivered vaginally (6 weeks samples: 72.2%; 12 months

samples: 70.9%), and did not have any systemic antibiotic exposure during initial hospitalization following
birth (6 weeks samples: 95.6%; 12 months samples
97.2%). The average birth weight was also similar across
subjects irrespective of the sample time point, 3370 g (±
480) for infants contributing 6-week samples and 3430 g
(±528) for infants contributing 12-month samples. Similarly, the average gestational age was 39.1 weeks (± 1.59)
(6-week samples) and 39 weeks (± 1.7) (12-month samples). At the time of 6-week sample collection, 62% of
infants had been exclusively breastfed while by the time
of 12-month sample collection, 59.2% of infants received
breast milk supplemented with formula, however a large
minority (35.1%) remained exclusively breastfed. There
were more male than female infants in the cohort
(53.8% male among infants contributing a 6-week sample; 56.4% male among infants contributing a 12-month
sample). Maternal smoking during pregnancy was rare
(6-week samples: 7%; 12-month samples: 5%).
Inter-omic sample distance comparison suggests overall
concordance between data sets

Global concordance between the microbiome and the
metabolome was observed across both time points and
metabolomic data sets (Fig. 2A, Figure S1A) when analyzed using a symmetric Procrustes test with samples
ordinated by Euclidean distances (Methods). It is noted
that the p-value at 6 weeks for the targeted data set (p =
0.057) was only trending close to significant at the 0.05
level.
Since the Procrustes test was performed on principal
coordinate (PCoA) ordinations of sample distances, the
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Table 1 Selected characteristics of subjects contributing
samples at 6 weeks (n = 158) and at 12 months of age (n = 282)
6 weeks
(n = 158)

12 months
(n = 282)

3370 (480)

3430 (528)

Birthweight (grams)
Mean (Standard Deviation)
Median [Minimum, Maximum]

3430 [1910, 4710]

3450 [1320, 4660]

Missing

2 (1.3%)

4 (1.4%)

Male

85 (53.8%)

159 (56.4%)

Female

73 (46.2%)

123 (43.6%)

Sex

Feeding Mode Until Time of Sample Collection
Unknown

6 (3.8%)

7 (2.5%)

Exclusively breastfed

98 (62%)

99 (35.1%)

Exclusively formula fed

13 (8.2%)

9 (3.2%)

Mixed

41 (25.9%)

167 (59.2%)

Vaginal

114 (72.2%)

200 (70.9%)

Cesarean

44 (27.8%)

82 (29.1%)

Mean (SD)

39.1 (1.59)

39.0 (1.70)

Median [Minimum, Maximum]

39.1 [33.4, 43.0]

39.1 [29.1, 42.0]

Delivery Mode

Gestational Age (Weeks)

Post-delivery infant systemic antibiotic exposure
No

151 (95.6%)

274 (97.2%)

Yes

7 (4.4%)

8 (2.8%)

Maternal smoking during pregnancy
No

143 (90.5%)

262 (92.9%)

Yes

11 (7.0%)

14 (5.0%)

Missing

4 (2.5%)

6 (2.1%)

Infant Race
Other

4 (2.5%)

13 (4.6%)

White

154 (97.5%)

269 (95.4%)

result is sensitive to the choice of dissimilarity metric. In
addition to standard Euclidean distances, the generalized
UniFrac (gUniFrac) metric was also leveraged to account
for phylogeny in calculating differences between samples. With gUniFrac, the association was not significant
at either time points for the targeted data set only (Fig.
2B), while the untargeted data set still maintained strong
concordance (6 weeks samples – p = 0.001; 12 months
samples – p = 0.006; Figure S1B).
Sparse canonical correlation analyses reveal the core set
of microbe-metabolite groups driving inter-omic
relatedness

Given broad concordance between the gut microbiome
and metabolome from sample distance analyses, we
employed sparse canonical correlation analysis (SCCA)

and pairwise Spearman rank correlation to ascertain the
strength of association as well as to identify core microbes and metabolites driving this relationship
(Methods).
The majority of taxa (65% of total genera at 6-weeks
and 80% at 12-months) and metabolites (100% of total
metabolites at 6-weeks and 80% at 12-months) were part
of significant (FDR threshold 0.05) Spearman pairwise
comparisons (Supplementary Note 1). This demonstrated a high level of congruence, where most microbes
are involved in metabolic processes captured in the stool
metabolome. This was also reflected in the significant
multivariate correlation (permutation p. < 0.001). However, at 6 weeks (correlation: 0.606 [0.61–0.73]), the degree of concordance was slightly higher than at 12
months (correlation: 0.52 [0.431–0.646]) but this difference was not significant due to overlapping confidence
intervals. The canonical correlation was overall slightly
higher in the untargeted data set (6 weeks: 0.636 [0.621–
0.733]; 12 months: 0.49 [0.475–0.702]), however the difference between time points was similar (Figure S2, Supplemental Note 2).
Using SCCA, we identified a core set of microbes and
metabolites that are major contributors to the multivariate correlation (Fig. 3, right panels; Supplementary Notes
2). Selected microbes (in both the targeted and untargeted data set) belonged to the Firmicutes, Actinobacteria and Proteobacteria phyla, as those are the most
commonly found phyla in the infant gut [25, 27]. However, previously established dominant genera such as
Bifidobacterium, Bacteroides and Lactobacillus were not
consistently selected across both time points. In the targeted data set Bifidobacterium was selected only at 6
weeks and Lactobacillus was only selected at 12 months.
Most notably, more microbes were selected at 12
months compared to 6 weeks in the targeted data set,
however in the untargeted data set this pattern was reversed (Figure S2, right panels). The majority of the selected metabolites in the targeted data set were amino
acids (Supplementary Table 1), with some short chain
fatty acids (SCFAs) selected at the 6-week time point.
Microbial community structure is weakly predictive of
stool metabolite relative concentrations

In order to determine how well the fecal metabolome
acts as a functional representation of the gut microbiome, we fitted metabolite-specific prediction models
based on taxonomic profiles. Chosen models include
random forest (RF), elastic net (EN), support vector machines with radial basis kernel (SVM-RBF) and sparse
partial least squares (SPLS), all of which had previously
been shown to work well with microbiome-associated
learning tasks [28]. Evaluation was based on predicted
R-squared (R2) and Spearman correlation coefficient
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Fig. 2 Inter-omics Procrustes biplots comparing PCoA ordinations of targeted metabolite profiles and taxonomic relative abundances for 6 weeks
(left panels) (n = 158) and 12 months (right panels) (n = 262). Top panels present analyses based on ordinations from Euclidean distances of
genus level abundances after centered log ratio transformation and Euclidean distances of log-transformed metabolite profiles. Bottom panel
presents analyses based on gUniFrac distance of amplicon sequence variant (ASV) relative abundances and Euclidean distances of logtransformed metabolite profiles. There were significant associations between the microbiome and the metabolome (both targeted and
untargeted) when utilizing Euclidean distances, however this association goes away when the gUniFrac distance was employed for the targeted
metabolites only

(SCC) as measured using 100 repeats of 5-fold nested
cross validation (Methods).
Predictive performance was more dependent on the
metabolite being predicted than by choice of model
(Fig. 4, Supplementary Notes 3, Supplementary Files 1).
Looking at predictive R2 (Fig. 4 panel A), the average
posterior mean performance across all models and metabolites was negative for both time points (− 5.6% at 6
weeks; − 3.07% at 12 months), which indicated that for
most prediction tasks the fitted model was less predictive than a naïve, intercept only model. At 6 weeks 22.2%
of metabolites had models that perform significantly better than the null (lower bound of 95% credible interval
larger than 0) while at 12 months 38.9% of metabolites
fit the classification. However, even among such

metabolites, the maximum R2 is only 11.8% at 6 weeks
and 8.7% at 12 months. Conversely, SCC values were
higher in comparison (cross-metabolite avg.: 0.339 at 6
weeks and 0.249 at 12 months) (Fig. 4 panel B, Supplementary Notes 3). At 6 weeks, 83% of metabolites were
significantly more performant than the null, while at 12
months all metabolites were selected. Using a more
stringent cutoff as used by Mallick et al. [29], the majority of metabolites at 6 weeks (69.4% of total metabolites)
still remained as well predicted while conversely at 12
months only 38.9% (of total metabolites) were
predictable.
Results from the untargeted analysis showed higher
performance values for both evaluation metrics (Supplementary Note 3). Specifically, 56.7% of metabolites bins
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Fig. 3 Pairwise Spearman correlation of concentration-fitted metabolites and genus-level taxonomic abundances for 6-weeks (panel A, N = 158)
and 12-months (panel B, N = 282) infants. Left panel displays the overall correlation pattern, where non-significant correlations are not colored
(false discovery rate (FDR) controlled q-value < 0.05). Right panel displays the same heatmap restricted to taxa and metabolites selected by the
sparse CCA procedure. Additionally, correlation coefficient of the first sCCA variate pair, bootstrapped 95% confidence interval and permutation pvalue are also reported. Significant microbiome-metabolome correlation was observed at both time points, however no significant difference was
found between the time points

at 6 weeks and 42.7% of bins at 12 months had R2 values
significantly higher than 0. However, under SCC, while
57% of metabolite bins at 6 weeks had SCC values significantly larger than 0.3 cutoff, only 28.8% of metabolite
bins at 12 months fit this criterion. Despite better performance, the overall average values were still low, suggesting that across the entire metabolome few
metabolites were highly predictable.

Despite weak predictive performance values, we were
still interested in determining a model that stands out as
the most appropriate for our prediction task. Aggregating
performance across metabolites stratified by model for
both evaluation metrics (Fig. 5, top panel), it can be observed that the average performances were similar (Supplementary Notes 3), for which no semi-targeted analyses
performed better on average than the naive model under
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Fig. 4 Forest plots of each prediction performance metric (R-squared – Panel A, Spearman correlation – Panel B) for each time point (6 weeks
(n = 158), 12 months (n = 282)) across all 36 metabolites and 4 machine learning models. 95% credible interval and predictive posterior means
were generated using Bayesian modelling of the evaluation statistic (Methods) after 100 repeats of 5-fold nested cross validation. Red vertical
lines indicate a value of 0 for the evaluation metric (equivalent to null model). Metabolites were classified as predictable if the null value did not
lie within the estimated 95% credible interval. For most metabolites, predictive performance was not significantly better than null models

R2. This is further illustrated when model performance
was aggregated by rank using Borda scores (Fig. 5, bottom
panel). A higher score indicated that a model was selected
as the top choice more times than others, where an even
score distribution across models corroborated the suggestion that no model was best across all prediction tasks.
That said, SVM-RBF seemed to be the highest scoring
model, particularly for the 6-week time point. The untargeted analysis also found similar results (Figure S3).

Sensitivity analyses

We performed both Procrustes and correlation analyses
on a data set restricted to the 65 subjects with paired
samples collected at both time points (6 weeks and 12
months). Each time point was analyzed separately similar
to our main analysis. In the targeted data set, significant
Procrustes concordance was observed at 12 months (pvalue = 0.003) but not at 6 weeks (p-value = 0.106). This
association was no longer significant when considering
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Fig. 5 Comparative analysis predictive model performance across all metabolites in the targeted dataset for both 6-weeks (n = 158) and 12months (n = 282) time points. Top panel shows superimposed boxplots and violin plots of the distribution of predictive posterior mean for each
evaluation metric across all 36 metabolites. Bottom panels show aggregated model rankings for all metabolites using R-squared (left) and
Spearman correlation (right) using Borda scores (Methods). Higher scores indicate that a model was consistently selected as a better performing.
Relatively similar Borda scores and cross-metabolite average predictive performances indicate that no model was clearly the most performant.
However, support vector machines (with radial basis function kernel) was highest scoring model

taxonomic ordination using the gUniFrac distance
metric (6 weeks). Surprisingly, in the untargeted data set,
no association was observed across both time points and
choice of distance metric (Figure S5, S6). In the canonical correlation analyses, significance was only observed
in the targeted data set at 6 weeks only (6 weeks: permutation p-value = 0.044; 12 months: permutation pvalue = 0.388). Even though most correlations were not
significantly different from the permuted null, the canonical correlation coefficient is higher at 6 weeks compared to 12 months in both the targeted (6 weeks: 0.676
[0.661–0.765]; 12 months: 0.52 [0.484–0.663]), and
untargeted (6 weeks: 0.703 [0.685–0.788]; 12 months:
0.444 [0.52–0.705]) data sets (Figure S7, S8).
Furthermore, to ascertain the uncertainty of model
choice, we evaluated all selected modelling approaches
with simulated data sets based on bootstrapped resampling of taxonomic relative abundances (Figure S4). For
the first simulation scenario, models were assessed
against generated metabolite concentrations under different degrees of model saturation (number of taxa associated with the outcome) and association strength
(signal to noise ratio). As expected, model performance

asymptotically reached perfect prediction with increasing
signal strength and model saturation, which demonstrated that prediction models were able to capture predictive associations should they arise even in sparse
microbiome data sets. Most notably, simulation performance differed more by signal-to-noise ratio than
model saturation, which indicated that the strength of
association plays a larger role in the observed weak predictive performance than the number of taxa involved.
Surprisingly, we obtained very similar results to our real
data values under our lowest simulation setting (model
saturation = 5%; signal-to-noise ratio 0.5). As such, it can
be suggested that the lack of predictability is due to
weak coupling rather than model choice.

Discussion
In this study, we provide a descriptive and hypothesis
generating analysis of the relationship between fecal microbial taxonomic abundances and metabolite concentrations with multi-omic profiling via paired targeted
sequencing of the 16S rRNA gene and H1 NMR metabolomics at multiple time points. Ecological, statistical and
machine learning approaches were applied to provide a
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multi-faceted view of this association. To our knowledge,
this study is one of the few comprehensive investigations
addressing the microbiome/metabolome interface in a
large general population cohort of infants.
The microbiome is significantly correlated but weakly
predictive of the metabolome

Overall global concordance was found from three independent methods (Procrustes analysis, SCCA and univariate Spearman correlation), consistent with previous
studies on both infant [19, 24] and adult populations
[17, 30]. This overall effect was found at both time
points, suggesting there coupling exists throughout infancy despite high levels of both inter- and intraindividual variability in taxonomic compositions [27].
Although our analyses demonstrated significant multivariate and univariate correlation between the microbiome and the metabolome, most metabolites were not
predictable when evaluated across multiple machine
learning models. Even among the small number of metabolites that are significantly predictable compared to
the null, the maximum performance values were still
low for both the untargeted and targeted analyses. When
compared to a recent study performing metabolite predictions from taxonomic abundances using an adult cohort [29], both the number of well-predicted metabolites
and the average performance values were much lower,
even when using similar evaluation criterion and cut
offs. It is unlikely that model choice was driving the lack
of predictability, since all chosen methods had been
shown to be suited for microbiome-associated prediction
tasks [28, 31] as well as covering both linear and nonlinear associations. This is further evidenced in our sensitivity analyses, where non-parametric simulations demonstrated that low predictability across both evaluation
metrics was driven by low signal-to-noise ratio rather
than model choice or number of taxa driving the
association.
These results can be attributed to the limitations of
our study design. We utilized partial 16S rRNA sequencing instead of whole genome shotgun sequencing. This
limits our taxonomic resolution to the Genus level for
most of the analysis [32]. Since bacterial functions relevant to human metabolism are likely to be strain specific
[33, 34], we hypothesized that aggregating to Genus level
might dilute the direct effects, where different strains
within the same Genus might have opposite impacts on
the abundance of a certain metabolite. This would result
in a lack of predictability as the same feature would contain elements that both increase and decrease the values
of the outcome of interest.
However, we can potentially attribute overall performance to other ecological processes. A likely candidate is
functional redundancy, an aspect ubiquitous in microbial
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communities [35], plays an important role in this weak
coupling. Functional redundancy is the ecological phenomena that multiple species representing a spectra of
taxonomic groups can perform similar roles [35, 36],
and is usually a marker for ecosystem resilience [37].
Under this paradigm, the loss of a certain metabolite
producing taxon would not impact the abundance of
that metabolite as other taxa in the community can
complement the functional role, complicating taxa to
metabolite predictions. This is evidenced in the Procrustes analysis where inter-omic associations are no longer
significant in Procrustes analyses when phylogenetic relatedness was adjusted using the gUniFrac distance
metric. Since gUniFrac adjusts for phylogeny by weighting the differences in proportions of each taxa across
two samples by the branch length from constructed evolutionary trees [38], the absence of an association suggests that samples with similar metabolic profiles might
be numerically comparable (cluster together under Euclidean distances) but with evolutionarily divergent taxonomic compositions. This is further supported by our
supplementary PICRUSt2 analyses, where we found for
most pathways no single genera dominate functional
contribution (Figure S10). Functional redundancy is also
consistent with previous research in human associated
microbiomes [39].
Taxa and metabolites selected to be core to the
microbiome-metabolome correlation reveal the
importance of amino acid metabolism

Taxa and metabolites with non-zero loading coefficients
in SCCA analyses were identified as factors driving this
overall correlation. The SCCA procedure utilized a L1penalized matrix decomposition of the cross-product
matrix akin to a LASSO regression problem [40], which
means that variables were selected based on their importance to the overall covariance between taxa and metabolite abundances.
At 6 weeks, two short chain fatty acids (SCFAs), butyrate and propionate, were selected as core to the
microbiome-metabolome interface. SCFAs (which includes compounds such as isobutyrate, and acetate) are
important metabolites obtained primarily from colonic
microbial fermentation of carbohydrates that escape digestion in the small intestines [41]. Butyrate is an energy
source for colonocytes [42] as well as participating in the
maintenance of the gut epithelial barrier through mucin
production [43]. Similarly, propionate is part of the gluconeogenesis pathway in liver hepatocyte cells, which is
core to lipid and energy metabolism in liver [44]. Most
importantly, SCFAs participate in immune programming
in early life, where the reduction in SCFA producing
bacteria is associated with inflammatory bowel disease
[45, 46].
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SCFA production in early life is linked to the Bifidobacterium and Bacteroides catabolism of human milk oligosaccharides (HMO) [47–49], which explains the
selection of the Bifidobacterium genera at 6 weeks where
infants are exclusively on a milk-based diet. This is further supported in our supplementary PICRUSt2 analysis,
where predicted pathways whose abundance significantly
correlate with butyrate concentrations were those associated with breakdown of sugars into butanoate (Figure
S9). The genera breakdown of those functions features
prominently Bacteroides, Bifidobacterium, Lachnoclostridium, Flavonifractor, and Clostridium sensu stricto 1
genera (Figure S10). This demonstrates that at 6 weeks,
infant microbiome-metabolome interaction is primarily
concerned with breakdown complex sugars into SCFAs,
cementing it’s functional role in microbiome development [50].
Surprisingly, the selected Bifidobacterium genus is
negatively correlated with butyrate abundance. We hypothesized that this might be due the complex crossfeeding relationship that exist between Bifidobacterium
and butyrate-producing taxa [51]. On one hand, some
Bifidobacterium species can be completely commensal,
producing secondary metabolites such as acetate that assist in the growth of butyrate producing species. On the
other hand, other Bifidobacterium strains such as B.
longum LMG 11047 and B. adolescentis can compete for
the same substrates as butyrate producing species [52].
The selection of the negative association between Bifidobacterium and butyrate suggests that butyratesuppressing Bifidobacterium strains might be more important in our infant samples.
However, the most selected metabolites in SCCA analyses are amino acids (7 out of 10 metabolites selected at
6 weeks were amino acids). Prior studies have shown
that the microbiota participate in regulating host amino
acid homeostasis by acting as both producers and utilizers [15]. The most common amino acid fermenters in
the human gut include those from the Clostridia class
[53]. Our results further support this as most selected
microbes with positive correlation with amino acids are
of the Eisenbergniella, Flavonifractor, Ruminococcaceae
UCG-004, Oscillibacter and Ruminiclostridium genera
under Clostridia. This is further seen in our supplemental PICRUSt2 analyses, where predicted abundance of
isoleucine and methionine biosynthesis pathways are significantly correlated with observed concentrations (Figure S9).
Aside from being fermenters, microbes can also either
directly utilize amino acids and incorporate them into
protein synthesis, or catabolize them as an energy
source, producing secondary metabolites. Even though
the process of amino acid catabolism for energy alone is
not energetically efficient [10], it produces secondary
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metabolites such as the aforementioned SCFAs, which
are important molecules in the metabolic interactions
between the microbiota and the host. However, amongst
selected microbes whose abundance are negatively correlated with amino acid concentrations (hence, suggestive of catabolism), we do not observe corresponding
positive correlation with selected SCFAs. We hypothesized that this might be due to the fact that bacterial
concentrations are higher in distal parts of the intestine
[9, 15] where nutrient availability is low. This lack of
available carbohydrates might incentivize microbes to
conserve energy by directly incorporating free amino
acids rather than metabolizing them. On the other hand,
prior studies suggested that microbial amino acid catabolism is compartment specific and occurs in more proximal regions [53, 54]. However, our study design is
limited to cross-sectional metabolomic profiling, which
limits the possibility of detecting SCFAs that are rapidly
produced and absorbed.
The microbiome is more tightly coupled with the
metabolome in early infancy

Results suggest some level of significant difference in
microbiome-metabolome coupling across development.
Canonical correlation, while not significantly different,
were lower at 12 months than at 6 weeks, suggesting a
time-varying effect. When looking at predictability, we
observed a higher number of well predicted metabolites
at 6 weeks compared to 12 months. Among those selected as well predicted metabolites, the average performance values (both R2 and SCC) where higher. This
is also replicated in the global untargeted data set. Furthermore, in our supplementary PICRUSt2 analyses,
there exists a higher number of significantly correlated
predicted pathway abundance to observed metabolite
concentrations (Figure S11), indicating increased metabolic coupling between the microbiome and the metabolome at 6 weeks compared to at 12 months.
There are various factors that can contribute to the
difference in microbiome-metabolome coupling between
infants at 6 weeks and 12 months. First, there exists substantive differences in dietary patterns for those included
in our analysis. The majority of infants at 6 weeks (62%)
were exclusively breastfed, while that number is markedly less (35%) at 12 months, where infants are also consuming complimentary solid family foods. This
transition in diet to solid foods have been shown to induce a change in the gut microbiome composition and
diversity due to increased amounts of fiber and protein
[55, 56], which might favor certain microbes over others.
Such changes in diet, particularly the cessation of breastmilk intake, also contributed towards the development
of infant gut microbiomes towards a more “adult like”
state [27, 55]. We hypothesized that earlier in life when
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infants are only consuming a limited type of food (predominantly breast milk or formula), the microbiome
participates more actively in host-microbiome cometabolic activity as infants are more reliant on microbes to breakdown complex nutrients [57]. Conversely,
at 1 year of age where the microbiome has matured, this
relationship is not as strongly coupled as a larger share
of the metabolome comes from host-produced
metabolites.
However, as analyses were conducted within each
timepoint independently with little subject overlap, further investigations are required to make more conclusive
statements about the potential time-varying effect of
microbiome-metabolome coupling. Particularly, aside
from differences in diet, factors such as differences in
antibiotic exposure [58] and maternal covariates [59]
might result in differences between time points. In future studies we hope to examine this factor using samples across multiple time points for the same infants.

Limitations

This study has various limitations. First, we utilized partial 16S rRNA gene sequencing instead of shotgun whole
genome sequencing, which limits our taxonomic resolution to the genus level for most of the analysis [33].
We hypothesized this lack of resolution contribute to
overall lack of predictability, as well as limiting the interpretability of variables selected by the SCCA process as
species and strain level differences can result in completely separate metabolic contributions [34]. For example,
we
cannot
disentangle
the
different
Bifidobacterium strains that might compete with butyrate producing taxa and generating the negative correlation between measured SCFAs and Bifidobacterium
abundance.
Second, our cohort includes only infants from the
NHBCS, a population-based cohort reflecting mostly
rural and White demographics of northern New England
in the United States. While this increases confidence in
the internal validity of our study, this homogeneity in
race and geography limits the generalizability of our results to other populations.
Third, our study is a cross-sectional survey of
microbiome-metabolome relationships at two different
time points. This means that we cannot capture associations relating to metabolites that are highly produced
and consumed. This means that the metabolites selected
might not be representative of the intricate relationship
between the microbiome and the metabolome. This interpretation is further limited by the lack of annotation
for our untargeted metabolite bins, which cannot be
compensated by the small number of metabolites selected for the targeted analyses.
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Finally, each time point was analyzed independently
with only 65 subjects with samples in both time points.
As such, this limits the ability to explore the differences
in coupling across the first year of life.

Conclusion
In conclusion, we conducted one of the first large-scale
multi-omics analysis of the microbiome-metabolome relationship using samples from a large birth cohort study
at 2 time points (6 weeks and 12 months). Although we
found global concordance between the microbiome and
the metabolome, the inter-omic concordance is weak,
where bacterial abundances at the genus level cannot accurately predict metabolite concentrations. We hypothesized that this might be due to functionally relevant
diversity at the strain level, as well as the impact of functional redundancy on the contribution of each microbe
to metabolite abundances. Additionally, we were able to
identify metabolites and microbes driving the overall
correlation. Results pointed to support the importance
of SCFA metabolism particularly at 6 weeks, as well as
the role of amino acid metabolism, either as a source of
SCFA and energy in the absence of carbohydrates, or as
a general mechanism for microbes to save energy as they
incorporate amino acids around their environment. Finally, our analysis suggests preliminary evidence that the
degree of microbiome-metabolome coupling changes
across time, being much more integrated at 6 weeks
compared to 1 year.
We conclude that although the metabolome is a functional output of the microbiome, there exists massive
challenges in being able to trace specific microbial contributions to host-microbe metabolism due to the complexity of factors such as functional redundancy and
strain level variability. As such, we recommend studies
to profile both the microbiome and the metabolome, as
aspects of microbial metabolic contributions cannot be
found solely through one omic data set. This is particularly important in settings where it is important to have
a mechanistic understanding of the role of microbes
such as developing of microbiome therapies [60].
Methods
Study population

Subjects for this study were from the New Hampshire
Birth Cohort Study (NHBCS) who provided infant stool
samples at 6-weeks and 12-months after birth. These
two timepoints are chosen as each correspond to routine
maternal postpartum visit, allowing sample collection
with minimal participant burden. Furthermore, at both
time points, infant feeding patterns are comparatively
more well established. As described in previous studies
[25, 59], NHBCS is a prospective study of mother-infant
dyads in New Hampshire, USA. Participants eligible are
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pregnant women between the ages of 18 and 45 years
old, currently receiving routine prenatal care at one of
the study clinics, consuming water out of a private well
with no intention to move prior to delivery. The Center
for the Protection of Human Subjects at Dartmouth provided institutional review board approval. All methods
were carried out in accordance with guidelines. Written
informed consent was obtained for participation from all
subjects for themselves and their children. Comprehensive sociodemographic, exposure and outcome data such
as infant feeding method, delivery mode, maternal smoking status, etc. were collected for all participants through
surveys, medical records and telephone interviews conducted during pregnancy, about 6 weeks postpartum,
and updated every 4 months up until first year of age
and every 6 months thereafter.
Collection of infant stool samples

Infant stool samples were collected at 6-weeks and 12months. Stool samples were provided in diapers and
stored by subjects in their home freezer (− 20 °C) until
they were able to return it to the study site. Stool was
thawed at 4 °C so that it could be aliquoted into cryotubes. Stools collected for 16S rRNA gene sequencing
were aliquoted (range 350–850 mg) into 3 ml RNAlater
and homogenized before storing at − 80 °C. Stools collected for metabolomic analysis were aliquoted (1–2 g)
into 15 ml centrifuge tubes before storing at − 80 °C.
Taxonomic profiling using 16S rRNA targeted gene
sequencing

RNAlater stool samples were thawed and DNA was extracted using the Zymo Fecal DNA extraction kit (Cat#
D6010, Zymo Research, Irvine, CA), according to the
manufacturer’s instructions. For each sample extraction,
400ul RNAlater stool slurry (50–100 mg of stool) was
used to isolate DNA. Extractions were performed in
batches of multiple samples and included a composite
RNAlater stool positive control and a RNAlater negative
control. Lysis was performed using 750ul Lysis Buffer in
ZR BashingBead™ Lysis Tubes (0.5 mm beads), mixed
and then shaken on a Disruptor Genie for 6 min. Eluted
DNA was quantified on a Qubit™ fluorometer using the
Qubit™ dsDNA BR Assay. Average coefficient of variation of DNA yields (ng/ul) for composite RNAlater
stool positive controls was 28%. No DNA was ever detectable in negative control elutions. Concentrations of
DNA samples used for 16S rRNA gene sequencing range
from 1 ng/ul to 25 ng/ul.
The V4-V5 hypervariable region of bacterial 16S rRNA
gene was sequenced at Marine Biological Laboratory in
Woods Hole, MA, using standard Illumina MiSeq amplicon approach (paired end sequenced between 518F and
926R) [61, 62]. As described previously [25, 59], 16S
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rDNA V4-V5 amplicons were generated from purified
genomic DNA samples using fusion primers. The use of
forward primers containing one of eight five-nucleotide
barcodes between the Illumina-specific bridge and sequencing primer regions and the 16S-specific region and
a single reverse primer containing 1 of 12 Illumina indices enables 96 samples per lane multiplexing. Amplifications were done in triplicate with one negative control
for internal quality control at MBL. We used qPCR
(Kapa Biosystems) to quantify the amplicon pool, and
one Illumina MiSeq 500 cycle paired end run to sequence each pool of 96 libraries. We demultiplex and divided datasets using Illumina MiSeq reporter and a
custom Python script. Demultiplexed reads derived from
Illumina sequencing were denoised and quality filtered
using DADA2 (v. 1.12.1) [63] in R (v. 3.6.1) [64]. Illumina adapter sequences were removed prior using cutadapt (v. 1.18). We utilized DADA2’s filterAndTrim
function to remove reads either containing a quality
score of 2 or lower (minQ = 2) or with expected errors
[65] of 2 (maxEE = c (2,2)) or higher. Post filtering, we
obtained an average of 119,800 reads per sample for 6week samples and 120,480 reads per samples for 12month samples. On average, we 74.7% of reads were
kept for 6-week samples and 76.3% of reads were kept
for 12-month samples. We then use the RDP classifier
implemented natively in the DADA2 R package with
SILVA database (v. 128) to profile the taxonomy of identified amplicon sequence variants (ASVs).
Functional profiling using untargeted and targeted 1H
NMR metabolomics
1

H NMR metabolomics was performed in collaboration
with the NIH Eastern Regional Comprehensive Metabolomics Resource Core (RCMRC) at UNC Chapel Hill.
De-identified stool aliquots were shipped on dry ice and
immediately stored at − 80 °C for metabolomics analysis.
Samples were thawed and ~ 150 mg of stool samples
were transferred to MagNA Lyser tubes after recording
the weight. Samples were then homogenized with 50%
acetonitrile in water by using the Omni Bead Disruptor
(Omni International, GA, USA). Homogenized samples
were centrifuged at 16000 rcf and the supernatant was
separated into another tube. An aliquot (1000 uL, 100
mg equivalent of fecal mass) was transferred into an
Eppendorf tube and lyophilized overnight. The dried extract was reconstituted in 700 uL of NMR master mix
(containing 0.2 M phosphate buffer, 0.5 mM DSS-d6 (internal standard), and 0.2% sodium azide (preventing bacterial growth)), vortexed on a multi tube vortexer at
speed 5 for 2 min and centrifuged at 16000 rcf for 5 min.
A 600 μl aliquot of the supernatant was transferred into
pre-labeled 5 mm NMR tubes. Additionally, study
pooled quality control (QC) samples (created from
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randomly selected study samples) and batch pooled QC
samples were generated from supernatants of study samples and aliquots of supernatants were dried and reconstituted similar to study samples described above and
used for QC purposes.
1
H NMR spectra of feces extracts were acquired on a
Bruker 700 MHz NMR spectrometer using a 5 mm cryogenically cooled ATMA inverse probe and ambient
temperature of 25 C. A 1D NOESY presaturation pulse
sequence (noesygppr1d [66, 67], [recycle delay, RD]-90°t1–90°-tm-90°-acquire free induction decay (FID)]) was
used for data acquisition. For each sample, 64 transients
were collected into 64 k data points using a spectral
width of 12.02 ppm, 2 s relaxation delay, 10 ms mixing
time, and an acquisition time of 3.899 s per FID. The
water resonance was suppressed using resonance irradiation during the relaxation delay and mixing time. NMR
spectra were processed using TopSpin 3.5 software (Bruker-Biospin, Germany). Spectra were zero filled, and
Fourier transformed after exponential multiplication
with line broadening factor of 0.5. Quality control measures included review of each NMR spectrum for line
shape and width, phase and baseline of spectra, and tight
clustering of QC samples in Principal Component Analysis [68]. NMR bin data (0.49–9.0 ppm) were generated
(untargeted data) excluding water (4.73–4.85 ppm) using
intelligent bucket integration of 0.04 ppm bucket width
with 50% looseness using ACD Spectrus Processor
(ACD Labs Inc., Toronto, Canada). The integrals of each
bin were normalized to the total spectral intensity of
each spectrum and transferred to analysis software. This
resulted in a collection of spectral bins with bin-specific
relative abundances, which will be called the untargeted
data. In addition, relative concentration of librarymatched metabolites (selected from the literature implicated to be important in host-microbe relationships Table S1) was determined by using Chenomx NMR
Suite 8.4 Professional software [26]. This data set will be
called the targeted data set.
Software and tools

All analyses were performed using the R programming
language (v. 3.6.3) [64] and associated packages. All data
wrangling steps were performed using phyloseq [69], plyr
and tidyverse packages [70], as well as the compositions
package [71] for log-ratio transformations. All figures
were generated using the ggplot2 [72], cowplot [73], viridis [74] and pheatmap [75] packages. Additionally, the
tidymodels [76] suite of packages was utilized to assist in
all modelling tasks. Specific packages used for modelling
will be enumerated below. All scripts as well as intermediary analysis objects are available on GitHub with all
dependencies and their versions (https://github.com/
qpmnguyen/infant_metabolome_microbiome).
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Data transformation and normalization

For microbiome data, we retained all ASVs present in at
least 10% of samples [29] and added one pseudocount to
all cells [77]. We then subsequently aggregated all ASVs
to the genus taxonomic level [28] and converted data to
relative proportions using total read counts by sample to
account for differential sequencing depth. We further filtered out taxa with mean relative proportion < 0.005%
[78]. This filtration step resulted in 46 genera for 6-week
samples and 72 genera for 12-month samples. To address the compositional problem induced by a sum to
one constraint, we apply the centered log ratio transformation (CLR), which is often used to remove such
constraints in microbiome data sets [79]. The CLR
transformation is favored compared to other statistically
equivalent log-ratio transformations due to its scale invariant property and ease of interpretation [80].
For metabolomic data sets, we employed different
transformations to approximate homoscedasticity depending on the data type (targeted vs untargeted). For
targeted metabolites, we performed a log(x + 1) transformation while for untargeted metabolites we utilized
the arcsine square root transformation which has been
previously used for transforming composition metabolomics data sets [29].

Distance matrix analyses

Principal coordinates analysis (PCoA) was performed
using the pcoa function from the ape package in R [81]
with sample distance matrices. The PCoA procedure
seeks to represent high dimensional multivariate data
sets in lower dimensions through eigen decomposition
of the doubly centered distance matrix. PCoA allows the
usage of non-Euclidean distances between samples such
as ecological indices, which makes it a preferable
method for sample ordination compared to principal
component analysis (PCA).
We constructed Euclidean distance matrices for both
metabolic and taxonomic profiles post data transformation described in the previous section. Additionally,
gUniFrac distances (alpha = 0.5) [62] were considered for
taxonomic data using the implementation provided in
the package MiSPU [63]. gUniFrac requires a phylogenetic tree, of which an approximate maximum likelihood
phylogenetic tree was constructed with representative
ASV sequences using FastTree (v 2.1) [64]. Multiple sequence alignment was performed using the AlignSeqs
function from the DECIPHER package in R [65] and
trees were midpoint rooted using phytools [66]. Since
multiple sequence alignment is not conserved under filtering and aggregation of ASVs, gUniFrac distance calculations were performed with pre-filtered ASV-level
abundances normalized to relative abundances.
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The first two axes of constructed ordinations were
then compared using a symmetric Procrustes procedure
implemented in the protest function in the vegan package [67]. Procrustes superimposes two ordinations by
translating and rotating the coordinates, which preserves
the general structure of the data. This method performs
a superimposition fit between two data sets minimizing
the sum-of-squared differences (m2), which describes
the degree of concordance between the two configurations normalized to unit variance. Significance is obtained by testing against the permuted null using a
permutation test. This method was shown to have more
power while also limiting type I error compared to the
traditional Mantel test in ecological analysis [82]. Significance was determined using a permutation test on the
sum of squared differences with 999 permutations [68].
Sparse canonical correlation and spearman correlation
analyses

Sparse canonical correlation analysis (sCCA) was performed to identify strongly associated metabolitemicrobe groups. sCCA seeks to find linear combinations
of variables from each dataset that maximizes the correlation with each other while simultaneously thresholding
variable specific weights to induce sparsity and performing variable selection. The correlation coefficient in the
first canonical variate quantifies the overall degree of
multivariate associations. As such, sCCA is a popular
method in integrating multi-omics datasets with the
ability to select more biologically relevant sets of features
compared to traditional ecological methods such as coinertia analysis [83]. In this study, we use the sCCA implementation in the package PMA in R [40] which uses
a novel penalized matrix decomposition procedure to
achieve sparsity [84]. We tune hyperparameters using a
permutation approach in the CCA.permute function
(nperms = 50) prior to fitting the final model. We obtain
the correlation coefficients as a measure of overall correlation between the two data sets and calculated a bootstrapped 95% confidence interval (nboot = 5000) as well
as performing a permutation test (nperm = 1000) at the
0.05 significance level. In order to keep the structure of
the data set across different permutations, we use the
function randomizeMatrix from the package picante in
R [85] using the richness null model, which randomizes
community abundances within samples to maintain
sample species richness.
Pairwise Spearman correlations were also performed
using the cor function in R. Hypothesis testing was done
using cor.test, with multiple hypothesis testing correction
using the Benjamini-Hochberg procedure using p.adjust.
An FDR value of 0.05 is used as cutoff for significance
pairwise correlations. Visualization was done using
pheatmap package in R.
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Predictive modelling and evaluation

We choose candidate models based on previous research
utilizing supervised learning with microbiome associated
prediction tasks [28, 29, 31]. Specifically, we chose random forest (RF) [86], support vector machine with radial
basis function kernel (SVM-RBF) [87], elastic net (EN)
[88] and sparse partial least squares (SPLS) [89], which
have all been shown to perform with high-dimensional
predictors. These models also support linear and nonlinear associations between the microbiome and the outcome of interest. Model fitting, parameter tuning, and
evaluation were done using caret package in R [90]. Parallel processing was performed using the doParallel [91]
and parallel packages.
We evaluate prediction performance by performing
100 repeats of 10-fold nested cross validation, whereby
within each training fold is a separate 5-fold crossvalidation procedure done to perform hyperparameter
selection when appropriate with parameter grids modelled after Pasolli et al. [31]. For RF, we set the number
of trees to be 500, and the number of features used in
each decision tree to be the square root of the number
of the original features. For SVM-RBF, we tuned across
a grid for the regularization parameter C (values 2−5,
2−3, …, 215) and the kernel width parameter γ (values
2−15, 2−13, …, 23). For EN, we tuned over a grid of the
regularization parameter λ and the L1 to L2 penalty ratio
α, where for each α value (spaced by 0.1) between 0
(equivalent to a LASSO model) and 1 (equivalent to a
ridge regression model), we evaluate 100 lambda values
chosen by the glmnet procedure. For SPLS, we kept the
concavity parameter κ constant at 0.5 while tuning the
number of components K (values 1, 2, …, 10) and the
thresholding parameter η (values 0.1,0.2, …, 0.9).
We utilize standard regression evaluation metrics include predictive R-squared (R2) and Spearman correlation coefficient (SCC).
These statistics were chosen due to their ability to capture two different aspects of the regression task. Predictive R2 captures the predicted residual sum of squares
(PRESS) normalized by the total sum of squares of the
outcome, thereby measuring predictive performance
while also putting it into context of a naive, intercept
only model. On the other hand, SCC quantifies the
monotonic association between true and predicted
values, providing perspective as to whether the predicted
values can capture the overall trend of the outcome.
Prior to evaluation, all metabolites were back transformed to their original scale. In order to perform comparisons between models across time points and
metabolites as well as ascertaining the uncertainty of
each evaluation metric, a Bayesian approach as presented in [92]. Specifically, a generalized Bayesian hierarchical linear model (with identity link and gaussian

Nguyen et al. BMC Microbiology

(2021) 21:238

standard error) in the following form was fitted for each
metabolite:
EvaluationStatistic∼Model þ ð1jrepeat Þ
þ ð1jrepeat : fold Þ
This model assumes that the distribution of the evaluation statistic as a linear function of model assignment,
with random intercepts varying among repeats and for
folds within each repeat. Models were fitted using implementation in the R package tidyposterior [93] using default weakly informative priors as described in the
rstanarm package [94]. Using this model, a predictive
posterior mean and 95% credible interval can be generated. The posterior mean is then used to rank the best
performing model for each metabolite according to the
evaluation metric of interest. Ranks are then aggregated
using the Borda method [95] to generate Borda scores.
In detail, for each metabolite, 4 points are added to the
top ranked model, 3 points to the second ranked model
and so on. The model with the highest total points for
each metric is the most performant model aggregated
across all prediction tasks.
Simulation design

Simulations were performed to examine the behavior of
models under known association/null settings in order
to validate findings. For the first simulation scenario, a
linear association between genus-level taxonomic abundance and log transformed metabolite concentrations
were simulated. The predictor matrix were bootstrapped
resamples of the community matrix post data processing. β coefficient values were sampled from the standard
normal distribution N(0, 1) values for each genus would
have a probability p (0.05, 0.1, 0.5, 0.95) of being 0 which
determines the sparsity of the coefficients (or the level of
model saturation). We generate metabolite outcome
values Y following the model
Y ¼ β0 þ Xβ þ ϵ
where X is the n × p simulated taxonomic predictor
matrix, β is the p × 1 previously defined coefficient vector, ϵ ∼ N(μ = 0, σ = σϵ) is the standard normal noise vector. Similar to Xiao et al. 2018 [96] and Shi et al. 2016
σðβ0 þXβÞ
6
[97], we set all β0 ¼ √10
and σ ϵ ¼ SNR
where signalto-noise ratio (SNR) are set at 0.5, 0.7, 3, 5 to simulate
both situations where noise is higher than signal and
vice versa. For each simulation setting, 100 data sets
were generated.
For the second simulation scenario, null models were
assessed through a permutation procedure using the picante package in R as described earlier. A total of 500
permutations was performed for each model.
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To evaluate the predictive capacity of models for each
simulation scenario, each data set was split into a train
and test set (80% train; 20% test). Within each training
set, a 10-fold cross validation procedure was employed
to tune any hyperparameters. Similar evaluation metrics
were assessed as described in the model fitting section.
Metagenomic prediction with PICRUSt2

We conducted a PICRUSt2 (version 2.3.0_b) [98] analysis to investigate the potential relationship between the
functional metagenome (obtained via in sillico predictions) and measurements of associated metabolites. We
performed this analysis for metabolites obtained in the
targeted data set. The PICRUSt2 pipeline was performed
on pre-filtered ASV sequences and abundance tables
using default settings. Snakemake was used to construct
the computational pipeline [99].
After obtaining predicted MetaCyc pathway abundances, for each metabolite, we selected a subset of the
pathways where the metabolite is a known product
(accessed via MetaCyc SmartTables; 6-week samples:
https://metacyc.org/group?id=biocyc13-50254-3
822215614, 12-month samples: https://metacyc.org/
group?id=biocyc13-50254-3822215614) and performed
spearman correlation analysis with the measured metabolite abundances. For each significant correlation (significance level defined as q-values below 0.05 following
the Benjamini-Hochberg procedure [100]), we profiled
the relative contributions of the top five Genera. Relative
contribution is calculated as total abundance of a pathway assigned to that Genus across all samples divided by
the total abundance of the pathway across all samples.
Additionally, pairwise spearman correlation between
all identified pathway abundances and targeted metabolite concentrations was also performed. Significance is
defined similarly as FDR adjusted q-values below 0.05.
Abbreviations
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Figure S1. Inter-omics Procrustes biplots comparing PCoA ordinations of
untargeted metabolite profiles and taxonomic relative abundances for 6
weeks (left panels) (n = 158) and 12 months (right panels) (n = 262). Top
panels present analyses based on ordinations from Euclidean distances of
genus level abundances after centered log ratio transformation and Euclidean distances of arcsine square root transformed metabolite relative
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abundances. Bottom panel presents analyses based on generalized Unifrac distance of amplicon sequence variant (ASV) relative abundances
and Euclidean distances of arcsine square root transformed metabolite
relative abundances. Figure S2. Pairwise Spearman correlation of metabolite bins and genus-level taxonomic abundances for 6-weeks (panel A,
N = 158) and 12-months (panel B, N = 282) infants. Left panel displays the
overall correlation pattern, where non-significant correlations are not colored (false discovery rate (FDR) controlled q-value < 0.05). Right panel displays the same heatmap restricted to taxa and metabolites selected by
the sparse CCA procedure. Additionally, correlation coefficient of the first
sCCA variate pair, bootstrapped 95% confidence interval and permutation
p-value are also reported. Figure S3. Comparative analysis predictive
model performance across all metabolites in the untargeted dataset for
both 6-weeks (n = 158) and 12-months (n = 282) timepoints. Top panel
shows superimposed boxplots and violin plots of the distribution of predictive posterior mean for each evaluation metric across all 208 spectral
bins. Bottom panels show aggregated model rankings for all metabolites
using R-squared (left) and spearman correlation (right) using Borda scores
(Methods). Figure S4. Results for positive (Panel A) and negative simulations (Panel B). Positive simulations were conducted based on bootstrapped resamples of the original data (12-month time point) and a
normally distributed outcome vector which represented a logtransformed metabolite profile. Different levels of model saturation (horizontal, model sparsity (spar) at 0.05, 0.1, 0.5, 0.95) and effect sizes (vertical,
signal-to-noise ratio (snr) at 0.5, 0.7, 3, 5) were assessed, with 100 data
sets generated for each setting combination. Negative simulations were
conducted based on permutations of the original data (12-month time
point), with a total of 1000 permutations. Highly negative outliers were
removed for the purposes of visualization. Figure S5. Inter-omics Procrustes biplots comparing PCoA ordinations of targeted metabolite profiles and taxonomic relative abundances in the sensitivity analyses for 6
weeks (left panels) (n = 65) and 12 months (right panels) (n = 65). Top
panels present analyses based on ordinations from Euclidean distances of
genus level abundances after centered log ratio transformation and Euclidean distances of arcsine square root transformed metabolite relative
abundances. Bottom panel presents analyses based on generalized Unifrac distance of amplicon sequence variant (ASV) relative abundances
and Euclidean distances of arcsine square root transformed metabolite
relative abundances. Figure S6. Inter-omics Procrustes biplots comparing
PCoA ordinations of untargeted metabolite bin relative concentrations
and taxonomic relative abundances in the sensitivity analyses for 6 weeks
(left panels) (n = 65) and 12 months (right panels) (n = 65). Top panels
present analyses based on ordinations from Euclidean distances of genus
level abundances after centered log ratio transformation and Euclidean
distances of arcsine square root transformed metabolite relative abundances. Bottom panel presents analyses based on generalized Unifrac distance of amplicon sequence variant (ASV) relative abundances and
Euclidean distances of arcsine square root transformed metabolite relative
abundances. Figure S7. Pairwise spearman correlation of concentrationfitted targeted metabolite concentrations and genus-level taxonomic
abundances for 6-weeks (panel A, N = 65) and 12-months (panel B, N =
65) infants in sensitivity analyses. Left panel displays the overall correlation pattern, where non-significant correlations are not colored (FDR
controlled q-value < 0.05). Right panel displays the same heatmap restricted to taxa and metabolites selected by the sCCA procedure. Additionally, correlation coefficient of the first sCCA variate pair, bootstrapped
95% confidence interval (nboot = 5000) and permutation p-value
(nperm = 1000) are also reported. Figure S8. Pairwise spearman correlation of untargeted metabolite bin relative concentrations and genuslevel taxonomic abundances for 6-weeks (panel A, N = 65) and 12months (panel B, N = 65) infants in sensitivity analyses. Left panel displays
the overall correlation pattern, where non-significant correlations are not
colored (FDR controlled q-value < 0.05). Right panel displays the same
heatmap restricted to taxa and metabolites selected by the sCCA procedure. Additionally, correlation coefficient of the first sCCA variate pair, bootstrapped 95% confidence interval (nboot = 5000) and permutation pvalue (nperm = 1000) are also reported. Figure S9: Spearman correlation
coefficients and 95% confidence intervals of significant correlations (qvalue < 0.05) between metabolite concentrations in the targeted data set
and the abundances of pathways that produce them. Pathway
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abundances were obtained via PICRUSt2 predictions, with pathwaymetabolite relationship retrieved from MetaCyc database. Both 6-week
(n = 158) and 12-month (n = 282) samples are represented. Figure S10.
Top five contributors at the Genus level for each significantly correlated
pathway-metabolite pair obtained using observed metabolite concentrations and predicted pathway abundances (spearman correlation with qvalue < 0.05). Panel A represents 6-week samples while panel B represents samples at 12-months. Relative contributions are calculated as the
total number of copies of genes mapped to a pathway across all samples
per Genus over the total number of gene copies assigned to that pathway. Figure S11. Heatmap representing overall spearman correlations
between predicted pathway abundances (obtained via PICRUSt2) and
metabolite concentrations in the targeted data set regardless of
pathway-metabolite annotations. Both 6-week (n = 158) (Panel A) and 12month (n = 282) (Panel B) samples are presented. Non-significant correlations (q-value > 0.05) are not colored. Table S1. Metabolites selected for
targeted analysis and their potential biological functions. Table S2.
Primers used for bacterial 16S rRNA gene sequencing.
Additional file 2. Pairs of microbes and targeted metabolites with
significant spearman correlations at q-value < 0.05 with their correlation
values for each time point.
Additional file 3. List of targeted metabolites with predictive R2 > 0 or
spearman correlation > 0.3 for each model across all time points.
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